The influence of the obesity paradox and chronic kidney disease on long-term survival in a Japanese cohort with peripheral arterial disease

Journal of Vascular Surgery

Volumn 52, Issue 1, 2010, Pages 110-117

  Kumakura, Hisao ^a   Kanai, Hiroyoshi ^a   Aizaki, Masahiro ^a   Mitsui, Kito ^a   Araki, Yoshihiro ^a   Kasama, Shu ^a   Iwasaki, Toshiya ^a   Ichikawa, Shuichi ^a  

^a Cardiovascular Hospital of Central Japan (Kitakanto Cardiovascular Hospital)   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BERAPROST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; SARPOGRELATE; TICLOPIDINE; TRIACYLGLYCEROL; WARFARIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; AMPUTATION; ARTERY DISEASE; ARTICLE; BODY MASS; BYPASS SURGERY; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; FIBRINOGEN BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HUMAN; INTERMITTENT CLAUDICATION; JAPANESE; KIDNEY FUNCTION; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; DIABETES MELLITUS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; ISCHEMIA; JAPAN; KAPLAN-MEIERS ESTIMATE; KIDNEY DISEASES; MALE; MIDDLE AGED; OBESITY; PERIPHERAL VASCULAR DISEASES; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVORS; TIME FACTORS;

EID: 77953687781     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.02.008     Document Type: Article

References (37)

1. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., and Fowkes F.G. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45 suppl S (2007) S5-S67
2. Golomb B.A., Dang T.T., and Criqui M.H. Peripheral arterial disease: morbidity and mortality implications. Circulation 114 (2006) 688-699
3. Thatipelli M.R., Pellikka P.A., McBane R.D., Rooke T.W., Rosales G.A., Hodge D., et al. Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial disease. J Vasc Surg 46 (2007) 62-70
4. Criqui M.H., Ninomiya J.K., Wingard D.L., Ji M., and Fronek A. Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality. J Am Coll Cardiol 52 (2008) 1736-1742
5. Sarnak M.J., Levey A.S., Schoolwerth A.C., Coresh J., Culleton B., Hamm L.L., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108 (2003) 2154-2169
6. Maithel S.K., Pomposelli F.B., Williams M., Sheahan M.G., Scovell S.D., Campbell D.R., et al. Creatinine clearance but not serum creatinine alone predicts long-term postoperative survival after lower extremity revascularization. Am J Nephrol 26 (2006) 612-620
7. Arvela E., Soderstrom M., Alback A., Aho P.S., Tikkanen I., and Lepantalo M. Estimated glomerular filtration rate (eGFR) as a predictor of outcome after infrainguinal bypass in patients with critical limb ischemia. Eur J Vasc Endovasc Surg 36 (2008) 77-83
8. O'Hare A.M., Bertenthal D., Shlipak M.G., Sen S., and Chren M.M. Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. J Am Soc Nephrol 16 (2005) 514-519
9. Shulman N.B., Ford C.E., Hall W.D., Blaufox M.D., Simon D., Langford H.G., et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13 (1989) I80-I93
10. Flegal K.M., Graubard B.I., Williamson D.F., and Gail M.H. Excess deaths associated with underweight, overweight, and obesity. JAMA 293 (2005) 1861-1867
11. Cui R., Iso H., Toyoshima H., Date C., Yamamoto A., Kikuchi S., et al. Body mass index and mortality from cardiovascular disease among Japanese men and women: the JACC study. Stroke 36 (2005) 1377-1382
12. Adams K.F., Schatzkin A., Harris T.B., Kipnis V., Mouw T., Ballard-Barbash R., et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355 (2006) 763-778
13. Thomas F., Bean K., Pannier B., Oppert J.M., Guize L., and Benetos A. Cardiovascular mortality in overweight subjects: the key role of associated risk factors. Hypertension 46 (2005) 654-659
14. Vlek A.L., van der Graaf Y., Sluman M.A., Moll F.L., and Visseren F.L. Metabolic syndrome and vascular risk in patients with peripheral arterial occlusive disease. J Vasc Surg 50 (2009) 61-69
15. Gurm H.S., Brennan D.M., Booth J., Tcheng J.E., Lincoff A.M., and Topol E.J. Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox). Am J Cardiol 90 (2002) 42-45
16. Lavie C.J., Milani R.V., and Ventura H.O. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53 (2009) 1925-1932
17. Davenport D.L., Xenos E.S., Hosokawa P., Radford J., Henderson W.G., and Endean E.D. The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality. J Vasc Surg 49 (2009) 140-147
18. Romero-Corral A., Montori V.M., Somers V.K., Korinek J., Thomas R.J., Allison T.G., et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368 (2006) 666-678
19. Galal W., van Gestel Y.R., Hoeks S.E., Sin D.D., Winkel T.A., Bax J.J., et al. The obesity paradox in patients with peripheral arterial disease. Chest 134 (2008) 925-930
20. Lavie C.J., Ventura H.O., and Milani R.V. The "obesity paradox": is smoking/lung disease the explanation?. Chest 134 (2008) 896-898
21. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., and Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163 (2001) 1256-1276
22. Marcoux C., Tremblay M., Fredenrich A., Jacques H., Krimbou L., Nakajima K., et al. Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects. Atherosclerosis 139 (1998) 161-171
23. Okamura T., Tanaka H., Miyamatsu N., Hayakawa T., Kadowaki T., Kita Y., et al. The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis 190 (2007) 216-223
24. Castelli W.P. Lipids, risk factors and ischaemic heart disease. Atherosclerosis 124 suppl (1996) S1-S9
25. Matsuo S., Imai E., Horio M., Yasuda Y., Tomita K., Nitta K., et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53 (2009) 982-992
26. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002) S1-S266
27. National Institutes of Health. Evidence-based guidelines: clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary (2002), National Heart, Lung, and Blood Institute, Bethesda, MD
28. Health and Welfare Statistics Association. Annual statistical report of national health conditions in Japan. Health and Welfare Statistics Association 56 (2009) 416-427
29. Mehler P.S., Coll J.R., Estacio R., Esler A., Schrier R.W., and Hiatt W.R. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation 107 (2003) 753-756
30. Walsh C.R., O'Donnell C.J., Camargo Jr. C.A., Giugliano R.P., and Lloyd-Jones D.M. Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J 144 (2002) 1003-1011
31. Sin D.D., Anthonisen N.R., Soriano J.B., and Agusti A.G. Mortality in COPD: role of comorbidities. Eur Respir J 28 (2006) 1245-1257
32. Terrier N., Senecal L., Dupuy A.M., Jaussent I., Delcourt C., Leray H., et al. Association between novel indices of malnutrition-inflammation complex syndrome and cardiovascular disease in hemodialysis patients. Hemodial Int 9 (2005) 159-168
33. Freeman L.M., and Roubenoff R. The nutrition implications of cardiac cachexia. Nutr Rev 52 (1994) 340-347
34. Aquilani R., Opasich C., Verri M., Boschi F., Febo O., Pasini E., et al. Is nutritional intake adequate in chronic heart failure patients?. J Am Coll Cardiol 42 (2003) 1218-1223
35. Komai H., Shibata R., Juri M., Matsushita K., Ouchi N., and Murohara T. Plasma adiponectin as a predictive factor of survival after a bypass operation for peripheral arterial disease. J Vasc Surg 50 (2009) 95-99
36. Paraskevas K.I., Baker D.M., Vrentzos G.E., and Mikhailidis D.P. The role of fibrinogen and fibrinolysis in peripheral arterial disease. Thromb Res 122 (2008) 1-12
37. Yusuf S., Hawken S., Ounpuu S., Bautista L., Franzosi M.G., Commerford P., et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366 (2005) 1640-1649